The Evidence Base Post 08 May 2025

Your guide to ISPOR 2025

Joanne Walker

With ISPOR 2025 taking place next week, final preparations are underway for this leading conference in health economics and outcomes research (HEOR). In this article, I share key details about the event and highlight partner content to help you plan your time in Montreal.

Key details

Dates: May 13–16, 2025
Location: Montreal Convention Centre, 1001 Place Jean-Paul-Riopelle, Montreal, QC, H2Z 2B3, Canada
Registration: Still open — register here

Conference program

As healthcare systems worldwide face increasing pressures, from economic constraints to rapid technological advances and evolving patient expectations, the role of HEOR has never been more central to global health discussions. Reflecting this, the ISPOR 2025 program has been carefully crafted to address the field’s growing diversity and complexity.

Developed by the program committee – co-chaired by Gregory Daniel (Eli Lilly and Company), Nicole Mittmann (Canada’s Drug Agency) and Elisabeth M Oehrlein (AppliedPX) – the agenda offers a variety of learning formats, including Spotlight Sessions, Workshops, Issue Panels, Educational Symposia and Exhibit Hall Theaters. These will cover 12 key topic areas and feature insights from experts across the HEOR community.

Ahead of the meeting, read our ‘Exploring the conference program’ articles, which highlight selected sessions and posters from across these themes.

Our partners

The Evidence Base is delighted to be working with several partners to bring selected coverage of their sessions and posters. If you are at the ISPOR 2025, be sure explore their research and sessions and stop by their booths.

Avalere Health – Booth 906

Specialists from Avalere will share their expertise in a series of sessions examining the post-IRA landscape:

What’s Next? Year 1 Learnings of Evidence Planning for IRA Drug Price Negotiation

Date and time: May 14, 10:15am – 11:15am
Moderator: Taylor T Schwartz (Avalere)
Speakers: Peter Neumann (Tufts Medical Center), Michael Ciarametaro (Avalere Health), Russ Montgomery (GSK US)

IRA Under Trump: What Is Next?

Date and time: May 14, 10:15am – 11:15am
Moderator: Michael Ciarametaro (Avalere Health)
Speakers: Lisa Joldersma (Avalere Health), Ulrich Neumann (Johnson & Johnson)

Navigating Complexities in Calculating Therapeutic Alternative Starting Points in CMS Data

Date and time: May 16, 8:00am – 9:00am
Moderator: Sarah Moselle (Avalere)
Speakers: Shanthy Krishnarajah (Johnson and Johnson), Neil Lund (Avalere Health), Jordan T Banks (Avalere Health)

Carrot Recruitment

The Evidence Base is pleased to be working with Carrot Recruitment as our Talent Hub partner. Reach out to Martin Anderson to discuss your recruitment needs.

Cardinal Health – Booth 1407

Real-world evidence (RWE) experts will be participating in ISPOR 2025 through an Exhibit Hall Theater and several posters sharing their latest research:

Unlocking the Potential of Routine Patient Health Records for RWE

Date and time: May 15, 1:00pm – 1:30pm
Speakers: Bruce Feinberg (Cardinal Health), Harlen Hays (Cardinal Health)

Posters:

Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients with Long-Term Survivorship – Tammy Schuler (Cardinal Health)
Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM) – Sarah Lucht (Cardinal Health)

Cencora – Booth 607

The team from Cencora are taking part in several sessions throughout the three days of the conference, including the sessions:

Prescription Drug Affordability Boards (PDABs): Are There Opportunities for Robust and Transparent Engagement?

Date and time: May 16, 8:00am – 9:00am
Moderator: Elaine Tate (Cencora)
Speakers: Andrew York (Maryland Prescription Drug Affordability Board), Tiffany Westrich-Robertson (International Foundation for Arthritis), Justin Nedzesky (Neurocrine Biosciences), Kathryn Chandra (Genentech USA, Inc.)

Bringing Us Together or Pushing Us Apart: Will JCA, HEMA, and Other Cross-Border Collaboration Initiatives Improve Patient Access?

Date and time: May 14, 3:15pm – 4:15pm
Moderator: Erika Wissinger (Cencora)
Speakers: Michael Drummond (University of York), Eldon Spackman (O'Brien Institute for Public Health, University of Calgary), Jon Campbell (National Pharmaceutical Council)

Selected research being presented includes:

Value of Multi-Indication Immunotherapies for the Treatment of Autoimmune Diseases in the United States (US) – Long Nguyen (Cencora)
Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools – Jane Y Ha (Cencora)

Certara – Booth 1214

Certara’s HEOR team will be presenting several posters, including:

Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews – Roman Casciano (Certara)
Evaluating the Feasibility of a Network Meta-Analysis Comparing Treatment Options in Polycythemia Vera – Noemi Hummel & Agnieszka Kopiec (Certara)

Flatiron – Booth 601

Flatiron will highlight methodologies designed to advance evidence generation and health outcomes research in oncology during ISPOR 2025. A featured session, that will explore the relevance and transportability of RWE, is:

Real-World Life-Cycle Evaluation for Precision Medicine: From Conceptualization to Successful Implementation

Date and time: May 14, 5:00pm – 6:00pm
Moderator: Dean Regier (BC Cancer - ARCC – UBC)
Speakers: Deirdre Weymann (BC Cancer), Emanuel Krebs (Cancer Control Research), Blythe Adamson (Flatiron Health)

Other research I look forward to exploring includes:

Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data – Harlan Pittell (Flatiron Health)
Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors – Kelly Magee (Flatiron Health)

Forian – Booth 1021

Michael Sicilia and Wouter van der Pluijm of Forian will be presenting four abstracts at the conference, including:

Inovalon – Booth 1507

With a growing recognition of the role social drivers of health play in shaping outcomes, Inovalon will present several studies exploring their impact on healthcare utilization and patient outcomes:

Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data – Karl M Kilgore (Inovalon)
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health – Emma Pennington (Inovalon)

LCP Health Analytics

I’m looking forward to attending the session with Emma Hawe exploring how trial data can support cost-effectiveness analyses, with a focus on relative efficacy and utility estimates.

Clinical Trial Design, Beyond the Regulatory

Date and time: May 15, 3:15pm – 4:15pm
Moderator: Kati Copley-Merriman (RTI Health Solutions)
Speakers: Lynda Doward (RTI Health Solutions), Emma Hawe (LCP Health Analytics), Shannon Cope (PRECISIONheor)

Emma, as past chair, will also join the ISPOR Statistical Methods in HEOR SIG Open Meeting on May 14 to share updates on key initiatives, including the group's project on external control arms. Emma's colleagues Jonathan Pearson-Stuttard (Partner & Head of Health Analytics) and Robert King (Consultant) will also be at the meeting – do reach out to connect with them. You can also find Robert presenting during Poster Session 1 on:

Wider Societal Impact of Reducing Prevalence of Obesity: A Comparison of US and UK Impact Frameworks

LexisNexis Risk Solutions – Booth 606

Camille Cook (Senior Director, Healthcare Strategy) and Carolyn Mike (Senior Manager, Data Science) will present two posters demonstrating how analyses of real-world, de-identified medical claims data can provide actionable insights that can help inform HEOR strategy and improve real-world outcomes.

Medlior – Booth 720

Meet Tara Cowling (President) and Eileen Shaw (Research Lead) in the exhibit hall at booth 720 to learn more about how Medlior’s RWD strategies and how Canada's healthcare data can unlock new opportunities.

OM1 – Booth 1500

A team of 10 specialists from OM1 will be at ISPOR 2025, with Jessica Probst (Principal, Real-World Evidence) discussing their research during Poster Session 2 on:

Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

The Evidence Base at ISPOR 2025

The Evidence Base will be providing exclusive coverage of ISPOR 2025, including daily session highlights and in-depth features on all three plenaries. Register on The Evidence Base and follow us on LinkedIn to stay informed and up to date with the latest insights and developments from the conference.